Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant.

Abstract:

:Fusion proteins consisting of the extracellular region of murine B7.1 or B7.2 and the Fc portion of murine IgG2a (B7-IgG) were evaluated for their ability to promote antitumor responses. Therapeutic administration of soluble B7-IgG in mice with established tumors induced complete regression of the tumor and increased the survival of mice. In three models, MethA, P815, and MB49, mice with 7-day-old established tumors were cured with two to three treatment cycles of B7-IgG, given twice a week. Even in mice with an established B16/F10 tumor (a poorly immunogenic melanoma), therapeutic treatment with B7-IgG alone slowed tumor growth and increased survival significantly. Still stronger antitumor activity was achieved when B7-IgG was used as a vaccine adjuvant mixed with irradiated tumor cells. In 80% of mice with 7-day-old B16 tumors, tumors regressed completely, and mice survived for at least 80 days. In all tumor models, B7.1-IgG and B7.2-IgG had similar antitumor activity. B7-IgG-mediated tumor rejection was dependent on T cells, specifically CD8 cells, as demonstrated by the failure of B7-IgG to induce tumor regression in severe combined immunodeficient or CD8-depleted mice. In addition, mice that were cured of an established tumor were protected against a rechallenge with the same tumor for at least 4 months, suggesting the generation of memory responses. Surprisingly, the antitumor activity of B7-IgG was independent of IFN-gamma, as demonstrated by tumor rejection in IFN-gamma knockout mice. Our findings demonstrate the potent capacity of B7-IgG to generate or enhance antitumor immune responses and suggest the clinical value of B7-IgG.

journal_name

Cancer Res

journal_title

Cancer research

authors

Sturmhoefel K,Lee K,Gray GS,Thomas J,Zollner R,O'Toole M,Swiniarski H,Dorner A,Wolf SF

subject

Has Abstract

pub_date

1999-10-01 00:00:00

pages

4964-72

issue

19

eissn

0008-5472

issn

1538-7445

journal_volume

59

pub_type

杂志文章
  • Pharmacokinetics and metabolism of vinblastine in humans.

    abstract::The pharmacokinetics of vinblastine in humans was examined using a radioimmunoassay specific for both the Vinca alkaloids and aromatic ring [3H]vinblastine. The data were consistent with a three-compartment open model system with the following values, alpha phase: t1/2=3.90+/-1.46 min; Vc=16.8+/-7.1 liters. beta phase...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Owellen RJ,Hartke CA,Hains FO

    更新日期:1977-08-01 00:00:00

  • The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells.

    abstract::Neuroblastoma (NB), a tumor originating from the sympathetic nervous system, is the most common extracranial neurological tumor of childhood. Human NB cells may differentiate in vitro under treatment with biological agents, as gamma-interferon (IFN-gamma) and tumor necrosis factor (TNF). Unfortunately, NB cell lines r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ponzoni M,Casalaro A,Lanciotti M,Montaldo PG,Cornaglia-Ferraris P

    更新日期:1992-02-15 00:00:00

  • Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells.

    abstract::Three widely studied cell lines were used to examine the nature of the G1 arrest induced in human tumor cells by ionizing radiation and its relation to p53 status. Cell lines MCF-7 and RKO express wild-type p53, whereas HT29 expresses mutant p53. Exponentially growing cells were irradiated with 6 Gy, and the progressi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nagasawa H,Li CY,Maki CG,Imrich AC,Little JB

    更新日期:1995-05-01 00:00:00

  • Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model.

    abstract::Many vaccines are dependent on adjuvants to augment the immunizing process. The vaccines being developed for active specific immunotherapy of cancer have also usually included an adjuvant in the clinical studies. Several cytokines have been identified which are participants in the immune response to new antigenic stim...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McCune CS,Marquis DM

    更新日期:1990-02-15 00:00:00

  • Epigenetic silencing of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in Mex- human cells.

    abstract::Regulation of the expression of the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) has been investigated in a number of human lymphoblastoid cell lines. In a number of Mex- cell lines that do not express methyltransferase activity, CpG sequences in the mgmt gene were hypomethylated with respect to met...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cairns-Smith S,Karran P

    更新日期:1992-10-01 00:00:00

  • Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.

    abstract::Ovarian cancer is resistant to the antiproliferative effects of transforming growth factor-beta (TGF-beta); however, the mechanism of this resistance remains unclear. We used oligonucleotide arrays to profile 37 undissected, 68 microdissected advanced-stage, and 14 microdissected early-stage papillary serous cancers t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0683

    authors: Sunde JS,Donninger H,Wu K,Johnson ME,Pestell RG,Rose GS,Mok SC,Brady J,Bonome T,Birrer MJ

    更新日期:2006-09-01 00:00:00

  • Inhibition of DNA excision repair by methotrexate in Chinese hamster ovary cells following exposure to ultraviolet irradiation or ethylmethanesulfonate.

    abstract::Previous results have suggested that methotrexate (MTX) could interfere with the repair of spontaneous DNA damage. To determine its effects on induced DNA damage, MTX was compared to hydroxyurea and arabinofuranosylcytosine (H/A), a drug combination known to block the DNA polymerase step of excision repair, for its ab...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Borchers AH,Kennedy KA,Straw JA

    更新日期:1990-03-15 00:00:00

  • Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.

    abstract::Activated ras oncogene transfection into suitable recipient cells has been shown to induce the metastatic phenotype (Thorgeirsson, et al., Mol. Cell. Biol., 5: 259-262, 1985). We have used this model system to study the correlation of basement membrane collagenolysis with metastatic propensity. The c-Ha-ras oncogene a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Garbisa S,Pozzatti R,Muschel RJ,Saffiotti U,Ballin M,Goldfarb RH,Khoury G,Liotta LA

    更新日期:1987-03-15 00:00:00

  • 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.

    abstract::Endocannabinoids have been implicated in cancer. Increasing endogenous 2-arachidonoylglycerol (2-AG) by blocking its metabolism inhibits invasion of androgen-independent prostate cancer (PC-3 and DU-145) cells. Noladin ether (a stable 2-AG analog) and exogenous CB1 receptor agonists possess similar effects. Conversely...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3136

    authors: Nithipatikom K,Endsley MP,Isbell MA,Falck JR,Iwamoto Y,Hillard CJ,Campbell WB

    更新日期:2004-12-15 00:00:00

  • The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity.

    abstract::Although altered expression of platelet-derived growth factor (PDGF)-A is a hallmark of many cancers, the importance of pro-PDGF-A conversion to PDGF-A in tumorigenesis and the cognate protease(s) is unknown. Pro-PDGF-A processing occurs at pairs of basic residues, likely involving the proprotein convertases (PCs). In...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Siegfried G,Khatib AM,Benjannet S,Chrétien M,Seidah NG

    更新日期:2003-04-01 00:00:00

  • Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma-infected cell line.

    abstract::Two kinds of growth-inhibitory substances were found in culture of a Rous sarcoma virus-transformed rat liver cell line, RSV-BRL. The two substances were purified from the serum-free culture medium and identified as transforming growth factor beta 1 and Mycoplasma-derived arginine deiminase (EC 3.5.3.6), respectively....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Miyazaki K,Takaku H,Umeda M,Fujita T,Huang WD,Kimura T,Yamashita J,Horio T

    更新日期:1990-08-01 00:00:00

  • Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53.

    abstract::A model for medulloblastoma-like primitive neuroectodermal tumors was established in rat using retrovirally transduced SV40 large T antigen (LT) as an inducing agent (O. D. Wiestler et al., Brain Pathol., 2: 47-59, 1992). A cell line isolated from such a tumor and clonal derivatives thereof were biologically and molec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Salewski H,Bayer TA,Eidhoff U,Preuss U,Weggen S,Scheidtmann KH

    更新日期:1999-04-15 00:00:00

  • Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.

    abstract::We evaluated the usefulness of L-dopa decarboxylase (DDC) as a tumor marker of neuroendocrine (NE) cell differentiation by measuring its expression in 432 human tumors of diverse types and origins. A subset of these tumors and cell lines derived from them also were studied for expression of two other general NE cell m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gazdar AF,Helman LJ,Israel MA,Russell EK,Linnoila RI,Mulshine JL,Schuller HM,Park JG

    更新日期:1988-07-15 00:00:00

  • Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.

    abstract::Triple-negative breast cancers (TNBC) are especially refractory to treatment due to their negative hormone receptor and ErbB2/HER2 status. Therefore, the identification of cancer-associated deregulated signaling pathways is necessary to develop improved targeted therapies. Here, we show that expression of the ceramide...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3069

    authors: Heering J,Weis N,Holeiter M,Neugart F,Staebler A,Fehm TN,Bischoff A,Schiller J,Duss S,Schmid S,Korte T,Herrmann A,Olayioye MA

    更新日期:2012-06-01 00:00:00

  • Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.

    abstract::The prodrug of 9-beta-D-arabinosylguanine (ara-G), nelarabine, demonstrated efficacy against T-cell acute lymphoblastic leukemia, and its effectiveness correlated with the accumulation of the triphosphate form (ara-GTP). Although in vitro investigations using purified deoxycytidine kinase (dCK) or deoxyguanosine kinas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rodriguez CO Jr,Mitchell BS,Ayres M,Eriksson S,Gandhi V

    更新日期:2002-06-01 00:00:00

  • Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.

    abstract::Hereditary ovarian cancers associated with germline mutations in either BRCA1 or BRCA2 were studied to determine whether somatic mutation of the P53 gene is required for BRCA-linked ovarian tumorigenesis and further, whether the spectrum of additional somatic molecular genetic alterations present in these tumors diffe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rhei E,Bogomolniy F,Federici MG,Maresco DL,Offit K,Robson ME,Saigo PE,Boyd J

    更新日期:1998-08-01 00:00:00

  • Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap.

    abstract::Cancer research has long been hampered by the limitations of the current model systems. Both cultured cells and mouse xenografts grow in an environment highly dissimilar to that of their originating tumor, frequently resulting in promising treatments that are ultimately clinically ineffective. The development of highl...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-16-1260

    authors: Morton JJ,Bird G,Refaeli Y,Jimeno A

    更新日期:2016-11-01 00:00:00

  • Rapid release of intracellular galectin-3 from breast carcinoma cells by fetuin.

    abstract::Galectin-3, a beta-galactoside binding protein, plays a significant role in cell to extracellular matrix interactions. Despite its extracellular expression, the precise physiological mechanisms that trigger its release from the intracellular milieu have not been characterized. The present analyses were, therefore, don...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhu WQ,Ochieng J

    更新日期:2001-03-01 00:00:00

  • Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization.

    abstract::beta 1-4 N-acetylglucosaminyltransferase (GnT-III) catalyzes the formation of bisecting N-acetylglucosamine (GlcNAc) in the biosynthesis of N-linked oligosaccharides. To examine the effect of bisecting GlcNAc on the natural killer (NK) cytotoxicity, the GnT-111 gene was introduced into NK-sensitive K562 cells that hav...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshimura M,Ihara Y,Ohnishi A,Ijuhin N,Nishiura T,Kanakura Y,Matsuzawa Y,Taniguchi N

    更新日期:1996-01-15 00:00:00

  • Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor.

    abstract::The bispecific murine monoclonal antibody (MAb) 1A10 has specificity for the human transferrin receptor (TfR) and the human tumor-associated antigen gp40. This antibody, therefore, functions as an "antigen fork" by binding to two distinct antigens on the same malignant cell. Highly purified 1A10 inhibits the growth of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Amoroso AR,Clark JI,Litwin S,Hsieh-Ma S,Shi T,Alpaugh RK,Adams GP,Wolf EJ,Ring DB,Weiner LM

    更新日期:1996-01-01 00:00:00

  • CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.

    abstract::The expression of osteopontin (OPN), CD44 variants, and integrins has been correlated with tumorigenesis and metastasis. Here we show that these proteins cooperate to enhance cell motility. First, we demonstrate that several different CD44 variants bind to OPN in an arginine-glycineaspartic acid-independent manner, bu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Katagiri YU,Sleeman J,Fujii H,Herrlich P,Hotta H,Tanaka K,Chikuma S,Yagita H,Okumura K,Murakami M,Saiki I,Chambers AF,Uede T

    更新日期:1999-01-01 00:00:00

  • Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity.

    abstract::Reduced oxygenation, or hypoxia, inhibits differentiation and facilitates stem cell maintenance. Hypoxia commonly occurs in solid tumors and promotes malignant progression. Hypoxic tumors are aggressive and exhibit stem cell-like characteristics. It remains unclear, however, whether and how hypoxia regulates cancer ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1605

    authors: Kim Y,Lin Q,Zelterman D,Yun Z

    更新日期:2009-12-15 00:00:00

  • A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.

    abstract::Although more than 100 different BRCA1 germ-line mutations have already been identified in breast and/or ovarian cancer families, we report for the first time a deleterious genomic rearrangement in BRCA1. A 1-kb deletion comprising exon 17 was found in a large breast and ovarian cancer family, leading to a frameshift ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Puget N,Torchard D,Serova-Sinilnikova OM,Lynch HT,Feunteun J,Lenoir GM,Mazoyer S

    更新日期:1997-03-01 00:00:00

  • Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct.

    abstract::An orthotopic human lung cancer model in nu/nu mice was used to study the effect of an antisense K-ras (AS-K-ras) retroviral construct on tumor growth in vivo. A 2-kilobase genomic AS-K-ras DNA fragment linked to a beta-actin promoter was cloned into the LNSX retroviral vector. The recombinant construct was packaged i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Georges RN,Mukhopadhyay T,Zhang Y,Yen N,Roth JA

    更新日期:1993-04-15 00:00:00

  • Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer.

    abstract::High amounts of nitric oxide (NO) produced by activated macrophages or NO donors are required to induce cytotoxicity and apoptosis in pathogens and tumor cells. High concentrations of NO may lead to nonspecific toxicity thereby limiting the use of NO donors in the treatment of cancer. In this study, we tested the poss...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pervin S,Singh R,Gau CL,Edamatsu H,Tamanoi F,Chaudhuri G

    更新日期:2001-06-15 00:00:00

  • The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases.

    abstract::The asymmetric organization of epithelial cells is a basic counter to cellular proliferation. However, the mechanisms whereby pro-growth pathways are modulated by intracellular factors that control cell shape are not well understood. This study demonstrates that the adaptor protein Amot, in addition to its established...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1995

    authors: Ranahan WP,Han Z,Smith-Kinnaman W,Nabinger SC,Heller B,Herbert BS,Chan R,Wells CD

    更新日期:2011-03-15 00:00:00

  • Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.

    abstract::RAF kinase inhibitor protein (RKIP) is a seminal regulator of intracellular signaling and exhibits both antimetastatic and antitumorigenic properties. Decreased expression of RKIP has been described in several human malignancies, including acute myelogenous leukemia (AML). As the mechanisms leading to RKIP loss in AML...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-3049

    authors: Hatzl S,Geiger O,Kuepper MK,Caraffini V,Seime T,Furlan T,Nussbaumer E,Wieser R,Pichler M,Scheideler M,Nowek K,Jongen-Lavrencic M,Quehenberger F,Wölfler A,Troppmair J,Sill H,Zebisch A

    更新日期:2016-06-15 00:00:00

  • Effects of metabolism on the binding of polycyclic hydrocarbons to nuclear subfractions of cultured AKR mouse embryo cells.

    abstract::A high-affinity localization of [2H]methylcholanthrene and/or its metabolites to a specific nuclear fraction (Fraction l) between 4 and 72 hr of exposure is described. Other carcinogenic hydrocarbons, such as benzo(a)pyrene and dibenz(a,h)anthracene, demonstrate a similar markded localization in Fraction l after 24 hr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Spelsberg TC,Zytkovicz TH,Moses HL

    更新日期:1977-05-01 00:00:00

  • Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.

    abstract::C/EBPα is an essential transcription factor involved in regulating the expression or function of certain cell-cycle regulators, including in breast cancer cells. Although protein arginine methyltransferases have been shown to play oncogenic roles in a variety of cancers, little is known about the role of arginine meth...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-3211

    authors: Liu LM,Sun WZ,Fan XZ,Xu YL,Cheng MB,Zhang Y

    更新日期:2019-06-01 00:00:00

  • Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes.

    abstract::The simian polyoma virus SV40 has been detected in specific human tumors including non-Hodgkin's lymphomas, although a causative role for the virus has not been convincingly demonstrated. Aberrant methylation of CpG islands in promoter regions is a frequent method of silencing tumor suppressor genes (TSGs) in cancers ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3307

    authors: Shivapurkar N,Takahashi T,Reddy J,Zheng Y,Stastny V,Collins R,Toyooka S,Suzuki M,Parikh G,Asplund S,Kroft SH,Timmons C,McKenna RW,Feng Z,Gazdar AF

    更新日期:2004-06-01 00:00:00